Ovarian cancer is one of the most challenging cancers affecting women. It often presents at an advanced stage, requires complex surgery, and frequently needs coordinated treatment involving chemotherapy, genetics, pathology, radiology, and long-term follow-up.

For many women, one of the most important decisions after diagnosis is deciding who should lead their treatment.

Should surgery be performed by a general gynecologist, a general surgeon, a surgical oncologist, or a gynaecologic oncologist?

The evidence consistently shows that women with ovarian cancer achieve better outcomes when their treatment is directed by a gynecologic oncologist. This is why major international organizations recommend referral to a gynecologic oncology specialist whenever ovarian cancer is suspected or diagnosed.

Who Is a Gynecologic Oncologist?

A gynecologic oncologist is an obstetrician and gynecologist who has undergone additional specialized training focused exclusively on cancers of the female reproductive system.

This includes expertise in:

• Ovarian cancer
• Fallopian tube cancer
• Primary peritoneal cancer
• Cervical cancer
• Endometrial cancer
• Vulvar cancer
• Vaginal cancer

Their training extends beyond surgery and includes chemotherapy, multidisciplinary cancer care, genetics, clinical research, survivorship, and management of recurrent disease.

Why Is Ovarian Cancer Different?

Unlike many other cancers, ovarian cancer treatment depends heavily on the quality of the initial surgery.

The first operation often determines:

• Accurate staging
• Extent of tumor removal
• Future treatment options
• Likelihood of recurrence
• Overall survival

Numerous studies have shown that one of the strongest predictors of survival in ovarian cancer is the amount of residual disease left behind after surgery. The goal is complete removal of all visible cancer whenever safely possible. Achieving this often requires highly specialized surgical expertise.

What Does the Research Show?

Several landmark studies have compared outcomes between patients treated by gynecologic oncologists and those treated by non-specialist surgeons.

One frequently cited study found that women undergoing surgery by gynecologic oncologists were more likely to receive optimal tumor removal and guideline-based treatment. Among patients with early-stage disease, the 5-year survival rate was approximately 86% when treated by a gynecologic oncologist compared with 70% when treated by non-specialists. In advanced disease, survival was also significantly improved.

Research using large population databases has demonstrated that women treated by gynecologic oncologists are more likely to receive standard-of-care surgery and chemotherapy, which translates into improved outcomes. Unfortunately, many women worldwide still do not receive specialist-led care.

The Importance of Complete Cytoreduction

A key concept in ovarian cancer treatment is cytoreductive surgery, also called debulking surgery.

The objective is to remove all visible cancer deposits.

This may require procedures involving:

• Peritoneum
• Omentum
• Diaphragm
• Bowel
• Spleen
• Liver surface
• Pelvic and para-aortic lymph nodes

These operations can be technically demanding and often extend beyond routine gynecologic surgery.

Gynecologic oncologists are specifically trained to perform these procedures and to determine when surgery is likely to benefit a patient versus when chemotherapy should be given first. This decision-making process is crucial for maximizing survival while minimizing complications.

It’s Not Just About Surgery

Many people assume ovarian cancer treatment is only about removing the tumor.

In reality, modern ovarian cancer care is far more complex.

A gynecologic oncologist coordinates:

• Accurate Diagnosis- Determining the exact tumor type and stage.
• Treatment Planning- Choosing between primary surgery and neoadjuvant chemotherapy.
• Genetic Testing- Identifying BRCA mutations and other hereditary cancer syndromes.
• Targeted Therapies- Determining eligibility for PARP inhibitors and other modern treatments.
• Multidisciplinary Care- Coordinating with medical oncologists, radiologists, pathologists, and radiation oncologists.
• Follow-Up Care- Monitoring for recurrence and managing long-term survivorship issues.

Each of these steps influences patient outcomes.

Does This Mean Other Specialists Are Not Important?

Not at all.

• Successful ovarian cancer treatment requires teamwork.
• Radiologists help define disease extent.
• Pathologists establish the diagnosis.
• Critical care specialists, anesthesiologists, nurses, physiotherapists, and palliative care teams all play essential roles.
• However, the evidence suggests that outcomes are improved when a gynecologic oncologist leads and coordinates this multidisciplinary care pathway.

Questions Every Woman Should Ask

If you or a loved one has been diagnosed with ovarian cancer, consider asking:

• Has my case been reviewed by a gynecologic oncologist?
• Am I being treated according to international guidelines?
• Is complete tumor removal achievable in my case?
• Do I need genetic testing?
• Has my case been discussed in a multidisciplinary tumor board?

These questions can help ensure that treatment decisions are based on the best available evidence.

The Bottom Line

Ovarian cancer is one of the most complex cancers affecting women. The quality of the first treatment often has a lasting impact on survival.

Research consistently demonstrates that women treated by gynecologic oncologists are more likely to receive appropriate staging, optimal surgery, guideline-directed therapy, and comprehensive multidisciplinary care. These factors are associated with improved outcomes and, in many studies, improved survival.

For women facing an ovarian cancer diagnosis, consulting a gynecologic oncologist is not simply obtaining another opinion—it may be one of the most important steps in achieving the best possible outcome.